Healthcare Triangle, Inc.

NASDAQ:HCTI

0.853 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 2.4132.9844.1097.067.7798.5269.83811.29211.9511.58811.0569.1898.07810.057.9538.9957.3617.5577.427
Cost of Revenue 1.6912.0863.6315.536.0726.5798.2459.4788.5228.4298.1626.925.3526.7045.7736.595.3595.5515.254
Gross Profit 0.7220.8980.4781.531.7071.9471.5931.8143.4283.1592.8942.2692.7273.3452.182.4052.0022.0062.173
Gross Profit Ratio 0.2990.3010.1160.2170.2190.2280.1620.1610.2870.2730.2620.2470.3380.3330.2740.2670.2720.2650.293
Reseach & Development Expenses 0.1750.2070.1270.1040.0540.1020.5392.771.4710.6461.0661.4832.2040.8130.7570.2740.550.4920.427
General & Administrative Expenses 1.0770.9041.1760.821.3641.6121.6281.2931.481.4511.3511.3790.7531.0481.260.1120.5830.9110.878
Selling & Marketing Expenses 0.2940.6310.8830.7821.1011.0261.7611.6021.8151.6511.741.961.3280.8050.6681.3210.4770.2610.336
SG&A 1.3711.5352.0591.6022.4652.6383.3892.8953.2953.1023.0913.3382.0821.8531.9281.4331.061.1721.269
Other Expenses 00.5340.1274.8440.7120.8020.8740.910.9090.8440.711-0.20100.2110.2110.20.2010.2020
Operating Expenses 1.5461.7422.1866.553.2313.5424.8026.5755.6754.5924.8685.6094.4972.8782.8961.9061.8111.8661.826
Operating Income -1.167-1.378-1.708-5.02-1.524-1.595-3.209-4.762-2.247-1.433-1.974-6.684-1.770.468-0.7160.4980.1910.140.277
Operating Income Ratio -0.484-0.462-0.416-0.711-0.196-0.187-0.326-0.422-0.188-0.124-0.179-0.727-0.2190.047-0.090.0550.0260.0190.037
Total Other Income Expenses Net -0.08-0.131-0.149-0.305-0.415-0.186-0.05-0.089-0.0551.029-0.016-0.088-0.221-0.164-0.0950.781-0.001-0.006-0.149
Income Before Tax -1.247-1.509-1.857-5.325-1.939-1.781-3.259-4.851-2.302-0.404-1.99-3.427-1.9910.303-0.8111.9570.190.1350.329
Income Before Tax Ratio -0.517-0.506-0.452-0.754-0.249-0.209-0.331-0.43-0.193-0.035-0.18-0.373-0.2460.03-0.1020.2180.0260.0180.044
Income Tax Expense 0.0020.0010.0050.0070.0040.0050.0190.0120.0370.0010.0210.0190.0010.0010.0030.0810.0510.0370.089
Net Income -1.249-1.51-1.862-5.332-1.943-1.786-3.278-4.863-2.339-0.405-2.011-3.447-1.9920.304-0.8141.8760.1390.0980.24
Net Income Ratio -0.518-0.506-0.453-0.755-0.25-0.209-0.333-0.431-0.196-0.035-0.182-0.375-0.2470.03-0.1020.2090.0190.0130.032
EPS -0.22-0.28-0.42-1.24-0.46-0.42-0.78-1.17-0.65-0.11-0.57-1.1-0.70.1-0.280.670.050.0280.069
EPS Diluted -0.22-0.28-0.42-1.24-0.46-0.42-0.78-1.17-0.65-0.11-0.57-1.1-0.690.1-0.280.670.050.0280.069
EBITDA -0.824-0.844-1.172-0.176-0.812-0.793-2.323-3.858-1.3380.498-1.263-2.552-1.5590.679-0.5050.6980.3920.3420.478
EBITDA Ratio -0.341-0.283-0.285-0.025-0.104-0.093-0.237-0.341-0.112-0.051-0.114-0.278-0.1930.068-0.0630.0780.0530.0450.064